Gynecologic oncology.
D000477:Alkylating Agents / Q000627:therapeutic use; D001201:Ascites / Q000150:complications; D001706:Biopsy; D003609:Dactinomycin / Q000627:therapeutic use; D004717:Endometrium / Q000601:surgery; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005833:Genital Neoplasms, Female / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000601:surgery; D010386:Pelvic Neoplasms / Q000188:drug therapy; D010996:Pleural Effusion / Q000150:complications; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D014625:Vaginal Neoplasms / Q000601:surgery; D014846:Vulvar Neoplasms / Q000175:diagnosis
D000477:Alkylating Agents; D003609:Dactinomycin; D005472:Fluorouracil; D008727:Methotrexate